EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast (Q83147969)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20208479%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20208479%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20208479%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Ossama Tawfik

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20208479%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Juan Palazzo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20208479%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Nurija Bilalovic

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20208479%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Eduardo Eyzaguirre

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20208479%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Lisa Mj Lee

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20208479%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Patrick Adegboyega

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20208479%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Jill Hagenkord

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20208479%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Zoran Gatalica

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20208479%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

5 March 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20208479%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20208479%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20208479%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20208479%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

644-653

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20208479%20AND%20SRC:MED&resulttype=core&format=json

An update on apocrine lesions of the breast

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Molecular pathology of breast apocrine carcinomas: a protein expression signature specific for benign apocrine metaplasia.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

The challenge of apocrine proliferations of the breast: a morphologic approach

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Androgens and androgen receptors in breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Androgen and estrogen receptor mRNA status in apocrine carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Identification of molecular apocrine breast tumours by microarray analysis.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Are triple-negative tumours and basal-like breast cancer synonymous? Authors' response

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Gene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB family

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Refinement of breast cancer classification by molecular characterization of histological special types

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Apocrine carcinomas of the breast in Turkish women: hormone receptors, c-erbB-2 and p53 immunoexpression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Histological and immunohistochemical analysis of apocrine breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

The role of the epidermal growth factor receptor in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testing.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Breast carcinoma in women over the age of 85: distinct histological pattern and androgen, oestrogen, and progesterone receptor status.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Poor prognostic significance of unamplified chromosome 17 polysomy in invasive breast carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Determination of HER-2 status and chromosome 17 polysomy in breast carcinomas comparing HercepTest and PathVysion FISH assay.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Whole genome SNP arrays as a potential diagnostic tool for the detection of characteristic chromosomal aberrations in renal epithelial tumors.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Androgens and androgen receptors: a clinically neglected sector in breast cancer biology

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Preferential HER-2/neu overexpression and/or amplification in aggressive histological subtypes of invasive breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Chromosome 17 aneusomy is associated with poor prognostic factors in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Aneusomy 17 in breast cancer: its role in HER-2/neu protein expression and implication for clinical assessment of HER-2/neu status

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

ERBB receptors and cancer: the complexity of targeted inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Mutations and response to epidermal growth factor receptor inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

EGFR gene and protein expression in breast cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Characterization of HER1 (c-erbB1) status in locally advanced breast cancer using fluorescence in situ hybridization and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Numerical aberrations of chromosomes 1 and 7 by fluorescent in situ hybridization and DNA ploidy analysis in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Numerical abnormalities of chromosome 7 in interphase cell nuclei of breast carcinoma have no impact on immunohistochemically determined EGFR status

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021

Chromosome 7 aneusomy in metaplastic breast carcinomas with chondroid, squamous, and spindle-cell differentiation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.50

7 January 2021